Filter posts

Canada Patent Utility: Former USPTO Director Interview at BIO Convention

David Kappos, former Director, US Patent and Trade Office and current Partner Cravath, Swaine and …

What OxyContin Tells Us About the Value of “Evergreening" and Patents

A few weeks ago, the  FDA announced that they would not allow generic versions of …

The Justness of Gene Patents

Most of the biotechnology world awaits the U.S. Supreme Court’s answer to the Question Presented, …

Patent Utility Requirements for Biopharmaceutical Inventions: How Much is Enough?

A debate between the innovative and generic perspectives on pharmaceutical patent law in Canada, moderated …

BIO Members Receive Patents for Humanity Award

The United States Patent and Trademark Office announced the winners of the Patents for Humanity …

Patent and Tech Transfer Sessions at 2013 BIO International Convention

Patent and Technology Transfer sessions feature prominently at the 2013 BIO International Convention in Chicago …

Kirtsaeng v. John Wiley & Sons: No Good Deed Goes Unpunished

The Supreme Court handed Kirtsaeng a victory last week finding his importation and resale of …

BIO IPCC Conference Launches Next Week

BIO’s IPCC Spring Conference is in San Diego next week, March 25-27.  Find this year’s …

Gene Patents: Common Sense from Down Under

Oh, crikey! The U.S. Supreme Court is currently reviewing briefs to consider whether preparations of …

Parallel Importation: A Disincentive for Developing World Access to Medicines

Parallel importation serves as a challenge to improving access to medicines in the developing world.  …